 bismuth subsalicyl treatment acut diarrhea children clinic studi bismuth subsalicyl bss double-blind placebo-control studi adjunct rehydr therapi children month acut diarrhea regimen mg/kg time day signific benefit bss group placebo decreas stool frequenc stool weight improv stool consist signific improv clinic well-b shorten diseas durat patient bss signific reduct durat hospit stay day placebo-tr patient day intraven fluid requir degre bss-treat group bismuth subsalicyl clearanc pathogen escherichia coli stool case differ placebo rotaviru elimin bismuth subsalicyl report advers effect blood bismuth serum salicyl level level toxic studi bss effect adjunct therapi acut diarrhea children demand nurs hospit staff